𝛼SK or Searchbullish
Singapore Market Roundup (12-Feb-2026): Citi keeps 'buy' on CLI, sets $3.40 target amid M&A
SUMMARY
- Citi maintains 'buy' on CLI, setting $3.40 TP amid M&A and rising FUM growth.
- Lim & Tan Securities rates Reclaims Global as 'buy' with a target price of 60c.
- Maybank's Ong increases Thomson Medical's target price due to enhanced Johor land value.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
- Singapore Market Roundup (12-Feb-2026): Citi keeps 'buy' on CLI, sets $3.40 target amid M&A12 Feb 2026
x